TRIB - Trinity BiotechEPS of -$0.27 revenue of $18M in-line March, 23 2023 09:24 AM Trinity Biotech plc 2023-03-23 09:24:04 ET Trinity Biotech press release ( NASDAQ: TRIB ): Q4 EPS of -$0.27 may not be comparable to consensus of -$0.06. Revenue of $18M (-7.8% Y/Y) in-line. For further details see: Trinity BiotechEPS of -$0.27, revenue of $18M in-line